PUT/INTUITIVE SURGICAL/300/0.01/20.06.25 Share Price

Warrant

DE000GG4F6C2

Real-time BOERSE MUENCHEN 13:25:48 02/07/2024 BST
0.064 EUR -5.88% Intraday chart for PUT/INTUITIVE SURGICAL/300/0.01/20.06.25
Current month+11.48%
1 month-36.45%
Date Price Change
02/07/24 0.064 -5.88%
01/07/24 0.068 +11.48%
28/06/24 0.061 +1.67%
27/06/24 0.06 -7.69%
26/06/24 0.065 -2.99%

Real-time BOERSE MUENCHEN

Last update July 02, 2024 at 01:25 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
Issuer Goldman Sachs
WKN GG4F6C
ISINDE000GG4F6C2
Date issued 27/02/2024
Strike 300 $
Maturity 20/06/2025 (353 Days)
Parity 100 : 1
Emission price 0.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.177
Lowest since issue 0.057
Delta-0.09x
Omega 4.986
Premium33.03x
Gearing55.68x
Moneyness 0.6877
Difference Strike -136.2 $
Difference Strike %-45.41%
Spread 0.02
Spread %24.10%
Theoretical value 0.0730
Implied Volatility 37.53 %
Total Loss Probability 83.52 %
Intrinsic value 0.000000
Present value 0.0730
Break even 292.17 €
Theta-0x
Vega0.01x
Rho-0x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
436.2 USD
Average target price
426.5 USD
Spread / Average Target
-2.24%
Consensus